Publications by authors named "Linus Lin"

Claim this Profile
I
Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans.
Roshni R Singaraja, Ian Tietjen, G Kees Hovingh, Patrick L Franchini, Chris Radomski, Linus Lin

J Lipid Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.
Harry R Chobanian, Yan Guo, Ping Liu, Marc D Chioda, Selena Fung, Linda Chang, Mark McLaughlin, Lin-Lin Shiao, Linus S Lin

ACS Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.
Shaoyi Sun, Richard Dean, Qi Jia, Alla Zenova, Jing Zhong, Andrea Lindgren, Linus Lin

Bioorg Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase.
Ping Liu, Terence G Hamill, Marc Chioda, Harry Chobanian, Selena Fung, Linda Chang, Linus S Lin, Lin-Lin Shiao, Ling Xu

ACS Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans.
Roshni R Singaraja, Suthesh Sivapalaratnam, Kees Hovingh, Marie-Pierre Dubé, José Castro-Perez, Heidi L Collins, Linus Lin, Geesje Dallinge-Thie

Circ Cardiovasc Genet· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.
Harry R Chobanian, Yan Guo, Ping Liu, Thomas J Lanza, Marc Chioda, Linda Chang, Linus S Lin

Bioorg Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
Harry R Chobanian, Yan Guo, Ping Liu, Marc Chioda, Thomas J Lanza, Linda Chang, Linus S Lin

ACS Med Chem Lett· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality.
Ping Liu, Thomas J Lanza, Marc Chioda, Carrie Jones, Harry R Chobanian, Linda Chang, Linus S Lin

ACS Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists.
Michael M-C Lo, Harry R Chobanian, Oksana Palyha, Yanqing Kan, Theresa M Kelly, Linus S Lin

Bioorg Med Chem Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, Kate A Raustad, Sheng-Ping Wang, Linus S Lin

J Pharmacol Exp Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
Iyassu K Sebhat, Christopher Franklin, Michael M-C Lo, David Chen, James P Jewell, Linus S Lin

ACS Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
Joseph M Metzger, Karen Gagen, Kate A Raustad, Liming Yang, Amanda White, Linus S Lin

Am J Physiol Endocrinol Metab· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant.
Ihor E Kopka, Linus S Lin, James P Jewell, Thomas J Lanza, Tung M Fong

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the interconversion of a new class of dibenzodiazepine sulfonamide atropisomers.
Christopher J Welch, Xiaoyi Gong, Wes Schafer, Harry Chobanian, Linus Lin, Mirlinda Biba

Chirality· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Mark Hadden, Allan Goodman, Cheng Guo, Peter R Guzzo, Alan J Henderson, Linus S Lin

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.
Cheng Guo, Peter R Guzzo, Mark Hadden, Bruce J Sargent, Larry Yet, Linus S Lin

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Jian Liu, Shuwen He, Tianying Jian, Peter H Dobbelaar, Iyassu K Sebhat, Linus S Lin

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.
Shuwen He, Peter H Dobbelaar, Jian Liu, Tianying Jian, Iyassu K Sebhat, Linus S Lin

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity.
Xiao-Ming Guan, Howard Chen, Peter H Dobbelaar, Yan Dong, Tung M Fong, Linus S Lin, Sloan Stribling

Cell Metab· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
Terence G Hamill, Linus S Lin, William Hagmann, Ping Liu, James Jewell

Mol Imaging Biol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists.
Wu Du, James P Jewell, Linus S Lin, Vincent J Colandrea, Jing C Xiao

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
Linus S Lin, Thomas Lanza, James P Jewell, Ping Liu, Carrie Jones

J Med Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells.
Jing Chen Xiao, James P Jewell, Linus S Lin, William K Hagmann, Tung M Fong

Brain Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist.
Linus S Lin, Sookhee Ha, Richard G Ball, Nancy N Tsou, Laurie A Castonguay

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
Ping Liu, Linus S Lin, Terence G Hamill, James P Jewell, Thomas J Lanza

J Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis